In a wide-ranging conversation, veteran general manager of Teva’s Italian Cluster Hubert Puech d’Alissac explores the reasons for the company’s growth in the region to become the generic market leader, post-COVID changes to the pharma industry, and the state of private-public relationships in Europe. Furthermore, d’Alissac touches on the responsibility of the private industry to secure the supply of medicines and signs off with his optimism for the future and desire to deliver on clients’ needs.
Europe is starting to realise that health – like energy, food, defence, and security – is a strategic priority that needs to be monitored and nurtured
